|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 9.800 SEK | -2.97% |
|
-2.00% | -42.18% |
| 08-20 | Promimic AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-19 | Promimic Q1 2026 operating loss at SEK 3.5 mln | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 18.45M | - | - | - | - | - |
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
- Stock Market
- Stocks
- PRO Stock
- Charts Promimic AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
